Join
Live feed
·
INSIDERFilingvia Quantisnow
Avalo Therapeutics Inc. logo

Chief Medical Officer Doyle Mittie exercised 108,234 shares at a strike of $11.40 and sold $2,230,367 worth of shares (108,234 units at $20.61) as part of a pre-agreed trading plan (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track AVTX (Avalo Therapeutics Inc.) and more on Quantisnow.